Chemir Acquires Lycoming Analytical Laboratories, Creates New Division: Chemir Pharma Services
St. Louis, Missouri - July 23, 2003 - Chemir announces the acquisition of Lycoming Analytical Laboratories in central Pennsylvania, a contract laboratory specializing in providing quality control (QC) testing to the pharmaceutical industry. The new company, Chemir Pharma Services, combines the capabilities of the Pennsylvania facility with the services of Chemir's St. Louis location.
Chemir Pharma Services offers complete CMC solutions for pharmaceutical development. Core services include synthetic chemistry, characterization of drug substance and packaging systems, QC release of API's and excipients, methods development and validation, preformulation evaluations and stability studies. "We're excited about this acquisition," says Phil Meeks, CEO of Chemir Pharma Services. "This acquisition will integrate QC capabilities into Chemir's core research and development expertise. This combination of services offers our customers a wide range of CMC support activities, enhancing their abilities to bring
#####
Contact:
Shri Thanedar, Ph.D.
CEO, Chemir Analytical Services
2672 Metro Blvd.
Maryland Heights MO 63043
314-422-8422
800-659-7659
www.chemir.com
info@chemir.com